Cargando…

Survival Impact of Aggressive Treatment and PD-L1 Expression in Oligometastatic NSCLC

Background: Studies have shown that aggressive treatment of non-small cell lung cancer (NSCLC) with oligometastatic disease improves the overall survival (OS) compared to a palliative approach and some immunotherapy checkpoint inhibitors, such as anti-programmed cell death ligand 1 (PD-L1), anti-pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gauvin, Camille, Krishnan, Vimal, Kaci, Imane, Tran-Thanh, Danh, Bédard, Karine, Albadine, Roula, Leduc, Charles, Gaboury, Louis, Blais, Normand, Tehfe, Mustapha, Routy, Bertrand, Florescu, Marie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7924378/ https://www.ncbi.nlm.nih.gov/pubmed/33498159 http://dx.doi.org/10.3390/curroncol28010059

Ejemplares similares

Improvement of EGFR Testing over the Last Decade and Impact of Delaying TKI Initiation
por: Blanc-Durand, Félix, et al.
Publicado: (2021)

Arterial thrombosis and coronavirus disease 2019 in a patient with cancer
por: Nassabein, Rami, et al.
Publicado: (2020)

Phase II multicenter trial combining nivolumab and radiosurgery for NSCLC and RCC brain metastases
por: Wong, Philip, et al.
Publicado: (2023)

Stereotactic Ablative Radiotherapy for oligo-progressive disease refractory to systemic therapy in Non-Small Cell Lung Cancer: A registry-based phase II randomized trial (SUPPRESS-NSCLC)
por: Bahig, Houda, et al.
Publicado: (2022)

Successful Treatment with Brigatinib after Alectinib-Induced Hemolytic Anemia in Patients with Metastatic Lung Adenocarcinoma—A Case Series
por: El Sayed, Rola, et al.
Publicado: (2022)

Surgical Complexity of Pulmonary Resections Performed for Oligometastatic NSCLC
por: Antonoff, Mara B., et al.
Publicado: (2022)

Chemotherapy in Metastatic NSCLC – New Regimens (Pemetrexed, Nab-Paclitaxel)
por: Blais, Normand, et al.
Publicado: (2014)

Genomic features and its potential implication in bone oligometastatic NSCLC
por: Liao, Rongxin, et al.
Publicado: (2023)

Renal cell carcinoma associated with peritumoral sarcoid-like reaction without intratumoral granuloma
por: Ouellet, Simon, et al.
Publicado: (2012)

Local ablative therapies in oligometastatic NSCLC-upfront or outback?—a narrative review
por: Tjong, Michael C., et al.
Publicado: (2021)

Role of Radiosurgery and Stereotactic Ablative Radiotherapy for Oligometastatic Non-Oncogene Addicted NSCLC
por: Badellino, Serena, et al.
Publicado: (2022)

Ectopic ACTH Cushing's syndrome caused by a large-cell neuroendocrine lung carcinoma responding to desmopressin
por: Larose, Stéphanie, et al.
Publicado: (2023)

SAT321 Ectopic ACTH Cushing's Syndrome Caused By A Large-cell Neuroendocrine Lung Carcinoma Responding To Desmopressin
por: Larose, Stephanie, et al.
Publicado: (2023)

Radiotherapy for oligometastatic tumor improved the prognosis of patients with non‐small cell lung cancer (NSCLC)
por: Gong, Hong‐yun, et al.
Publicado: (2019)

Brain metastasis from urachal carcinoma: the importance of locally aggressive treatment
por: Taussky, Daniel, et al.
Publicado: (2012)

Patient Selection for Local Aggressive Treatment in Oligometastatic Non-Small Cell Lung Cancer
por: Werner, Raphael S., et al.
Publicado: (2021)

Oligometastatic breast cancer and metastasis-directed treatment: an aggressive multimodal approach to reach the cure
por: Merloni, Filippo, et al.
Publicado: (2023)

A Call for the Aggressive Treatment of Oligometastatic and Oligo-Recurrent Non-Small Cell Lung Cancer
por: Patel, Pretesh R., et al.
Publicado: (2012)

Local treatment of synchronous oligometastatic non-small cell lung cancer (NSCLC)—current consensus and future perspectives
por: Almeldin, Doaa Said, et al.
Publicado: (2020)

Oligometastatic Prostate Cancer
por: Stevens, Daniel J., et al.
Publicado: (2016)

Imaging of Oligometastatic Disease
por: Vietti Violi, Naik, et al.
Publicado: (2022)

Canadian Consensus Recommendations on the Management of MET-Altered NSCLC
por: Cheema, Parneet K., et al.
Publicado: (2021)

Cure of Oligometastatic Classic Biphasic Pulmonary Blastoma Using Aggressive Tri-modality Treatment: Case Series and Review of the Literature
por: Lewis, Jennifer A, et al.
Publicado: (2018)

The biology and treatment of oligometastatic cancer
por: Reyes, Diane K., et al.
Publicado: (2015)

Radiotherapy for Oligometastatic Lung Cancer
por: Bergsma, Derek P., et al.
Publicado: (2017)

Highlights on the Management of Oligometastatic Disease
por: Alshehri, Salem M., et al.
Publicado: (2020)

Endoscopic nodal staging in oligometastatic non-small cell lung cancer (NSCLC) being treated with stereotactic ablative radiotherapy (ENDO-SABR)
por: Dhaliwal, Inderdeep, et al.
Publicado: (2022)

Follow-Up Imaging Guidelines for Patients with Stage III Unresectable NSCLC: Recommendations Based on the PACIFIC Trial
por: Ko, Jenny J., et al.
Publicado: (2023)

Current and Emerging Role of Monoclonal Antibody-Based First-Line Treatment in Advanced Gastro-Esophageal and Gastric Cancer
por: Désilets, Audrey, et al.
Publicado: (2023)

Surgical treatment in oligometastatic breast cancer
por: Vargas, Catalina, et al.
Publicado: (2019)

Role of surgery in oligometastatic prostate cancer
por: Jenjitranant, Pocharapong, et al.
Publicado: (2019)

Radiation therapy for oligometastatic oropharyngeal cancer
por: Martini, Stefania, et al.
Publicado: (2020)

Brachytherapy for oligometastatic prostate cancer to the penis
por: Martz, Nicolas, et al.
Publicado: (2021)

Oligometastatic Breast Cancer: How to Manage It?
por: Barberi, Vittoria, et al.
Publicado: (2021)

Multimodal treatment in oligometastatic gastric cancer
por: Chevallay, Mickael, et al.
Publicado: (2022)

The Role of Surgery in Oligometastatic Retroperitoneal Sarcoma
por: Janes, Lindsay A., et al.
Publicado: (2023)

Canadian Consensus Recommendations on the Management of KRAS G12C-Mutated NSCLC
por: Cheema, Parneet K., et al.
Publicado: (2023)

Oligometastatic breast cancer: A mini review
por: Rastogi, Sameer, et al.
Publicado: (2014)

Stereotactic Ablative Radiotherapy for Oligometastatic Disease in Liver
por: Kim, Myungsoo, et al.
Publicado: (2014)

Oligometastatic prostate cancer: Metastases-directed therapy?
por: Van Poppel, Hein, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_jt31kt8tevsa7co1aasun9asvc